CaboPoint and the Future of Renal Cell Carcinoma Trials: Sequencing, Biomarkers, and Strategy.

Authors

Atulya A. Khosla, Corewell Health East Resident
Ali Moradi
Karan Jatwani

Document Type

Article

Publication Date

11-19-2025

Publication Title

European urology

Volume

S0302-2838

Issue

25

First Page

04791-8

Recommended Citation

Khosla AA, Moradi A, Jatwani K. CaboPoint and the future of renal cell carcinoma trials: sequencing, biomarkers, and strategy. Eur Urol. 2025 Nov 19:S0302-2838(25)04791-8. doi: 10.1016/j.eururo.2025.11.001. Epub ahead of print. PMID: 41266219.

DOI

10.1016/j.eururo.2025.11.001

ISSN

1873-7560

PubMed ID

41266219